Novolog (Pharm-Up 1966) Ltd (TLV:NVLG)

Novolog (Pharm-Up 1966) Ratios and Metrics

Market cap in millions ILS. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 24, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	662	925	726	1,409	1,504	1,423
Market Cap Growth	-12.64%	27.45%	-48.50%	-6.30%	5.66%	81.80%
Enterprise Value	648	904	674	1,470	1,449	1,385
Last Close Price	1.30	1.79	1.34	2.56	2.69	2.72
PE Ratio	32.98	23.39	-	29.66	35.53	35.52
Forward PE	-	14.02	14.02	14.02	14.02	14.02
PS Ratio	0.32	0.46	0.44	0.93	1.20	1.25
PB Ratio	1.70	2.42	1.83	3.03	3.50	4.81
P/TBV Ratio	11.78	17.47	10.37	13.19	9.06	19.23
P/FCF Ratio	7.50	6.37	4.43	16.07	28.51	43.30
P/OCF Ratio	6.49	5.84	3.63	10.62	18.03	24.34
EV/Sales Ratio	0.32	0.45	0.41	0.98	1.15	1.22
EV/EBITDA Ratio	4.70	8.47	5.01	14.40	15.81	17.29
EV/EBIT Ratio	9.22	12.43	12.50	18.90	20.87	24.07
EV/FCF Ratio	7.34	6.23	4.12	16.77	27.46	42.13
Debt / Equity Ratio	0.49	0.52	0.54	0.46	0.39	0.52
Debt / EBITDA Ratio	1.38	1.53	1.36	1.74	1.55	1.62
Debt / FCF Ratio	2.16	1.37	1.31	2.43	3.16	4.69
Asset Turnover	0.69	0.69	0.63	0.64	0.56	0.52
Inventory Turnover	5.91	6.53	6.74	7.07	4.97	4.26
Quick Ratio	0.80	0.83	0.85	0.87	0.92	0.84
Current Ratio	0.96	0.96	0.96	0.98	1.03	0.99
Return on Equity (ROE)	5.20%	10.54%	-9.15%	11.38%	12.35%	14.50%
Return on Assets (ROA)	1.49%	1.56%	1.29%	2.06%	1.94%	1.66%
Return on Capital (ROIC)	7.41%	7.63%	5.24%	7.63%	8.29%	8.25%
Return on Capital Employed (ROCE)	12.40%	12.60%	8.90%	11.40%	11.60%	12.70%
Earnings Yield	3.03%	4.28%	-5.79%	3.37%	2.81%	2.81%
FCF Yield	13.33%	15.69%	22.57%	6.22%	3.51%	2.31%
Dividend Yield	3.08%	2.74%	2.20%	2.56%	3.49%	0.95%
Payout Ratio	124.55%	101.17%	-	67.14%	75.62%	29.95%
Buyback Yield / Dilution	-0.01%	0.04%	0.94%	-0.14%	-9.08%	-22.05%
Total Shareholder Return	3.06%	2.78%	3.15%	2.42%	-5.59%	-21.10%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.